- Home
- YSXT vs KPTI Comparison
YSXT vs KPTI Comparison
Compare YSXT & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- KPTI
- Stock Information
- Founded
- YSXT 2011
- KPTI 2008
- Country
- YSXT China
- KPTI United States
- Employees
- YSXT N/A
- KPTI N/A
- Industry
- YSXT Automotive Aftermarket
- KPTI Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- KPTI Health Care
- Exchange
- YSXT Nasdaq
- KPTI Nasdaq
- Market Cap
- YSXT 58.6M
- KPTI 44.5M
- IPO Year
- YSXT 2024
- KPTI 2013
- Fundamental
- Price
- YSXT $3.28
- KPTI $6.16
- Analyst Decision
- YSXT
- KPTI Buy
- Analyst Count
- YSXT 0
- KPTI 6
- Target Price
- YSXT N/A
- KPTI $39.80
- AVG Volume (30 Days)
- YSXT 548.1K
- KPTI 106.2K
- Earning Date
- YSXT 07-31-2025
- KPTI 11-04-2025
- Dividend Yield
- YSXT N/A
- KPTI N/A
- EPS Growth
- YSXT N/A
- KPTI N/A
- EPS
- YSXT 0.18
- KPTI N/A
- Revenue
- YSXT $71,452,736.00
- KPTI $137,269,000.00
- Revenue This Year
- YSXT N/A
- KPTI $3.67
- Revenue Next Year
- YSXT N/A
- KPTI $9.40
- P/E Ratio
- YSXT $14.54
- KPTI N/A
- Revenue Growth
- YSXT 22.04
- KPTI N/A
- 52 Week Low
- YSXT $1.68
- KPTI $3.51
- 52 Week High
- YSXT $9.96
- KPTI $16.95
- Technical
- Relative Strength Index (RSI)
- YSXT 65.34
- KPTI 51.64
- Support Level
- YSXT $2.38
- KPTI N/A
- Resistance Level
- YSXT $2.80
- KPTI $6.85
- Average True Range (ATR)
- YSXT 0.33
- KPTI 0.49
- MACD
- YSXT 0.14
- KPTI -0.38
- Stochastic Oscillator
- YSXT 39.34
- KPTI 75.58
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.